LON:MXF - Medicx Fund Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 0.89 +0.10 (+12.63 %)
(As of 02/15/2019 04:00 PM ET)
Previous CloseGBX 0.89
Today's RangeGBX 0.88 - GBX 0.89
52-Week RangeGBX 76.75 - GBX 92.50
Volume1.35 million shs
Average Volume412,813 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 154 properties. The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.4 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7.7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 180,000 customers. Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority. The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement. The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.

Receive MXF News and Ratings via Email

Sign-up to receive the latest news and ratings for MXF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry REIT - Healthcare Facilities
SectorReal Estate



Sales & Book Value

Annual SalesN/A



OptionableNot Optionable

Medicx Fund (LON:MXF) Frequently Asked Questions

What is Medicx Fund's stock symbol?

Medicx Fund trades on the London Stock Exchange (LON) under the ticker symbol "MXF."

How often does Medicx Fund pay dividends? What is the dividend yield for Medicx Fund?

Medicx Fund announced a dividend on Friday, February 8th. Shareholders of record on Thursday, February 14th will be given a dividend of GBX 0.95 per share on Friday, March 29th. This represents a yield of 1.06%. The ex-dividend date of this dividend is Thursday, February 14th. The official announcement can be viewed at this link. View Medicx Fund's Dividend History.

What price target have analysts set for MXF?

2 brokerages have issued twelve-month price objectives for Medicx Fund's stock. Their predictions range from GBX 76 to GBX 90. On average, they anticipate Medicx Fund's share price to reach GBX 83 in the next year. This suggests a possible upside of 9,204.9% from the stock's current price. View Analyst Price Targets for Medicx Fund.

What is the consensus analysts' recommendation for Medicx Fund?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medicx Fund in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medicx Fund.

Has Medicx Fund been receiving favorable news coverage?

Media headlines about MXF stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Medicx Fund earned a news impact score of 1.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Who are some of Medicx Fund's key competitors?

Who are Medicx Fund's key executives?

Medicx Fund's management team includes the folowing people:
  • Mike Adams, Chief Exec. Officer

How do I buy shares of Medicx Fund?

Shares of MXF and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Medicx Fund's stock price today?

One share of MXF stock can currently be purchased for approximately GBX 0.89.

What is Medicx Fund's official website?

The official website for Medicx Fund is http://www.medicxfund.com.

How can I contact Medicx Fund?

Medicx Fund's mailing address is Regency Court, Glategny Esplanade, ST PETER PORT, GY1 1WW, Guernsey. The company can be reached via phone at +44-1481-723450.

MarketBeat Community Rating for Medicx Fund (LON MXF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  86 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  195
MarketBeat's community ratings are surveys of what our community members think about Medicx Fund and other stocks. Vote "Outperform" if you believe MXF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MXF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel